78467 Konstanz, de
+41 (71) 4500-668
Resaphene Suisse AG: European Patent Office announces patent for tinnitus therapy
"We identified the heatable in-ear headphones we developed as the key to successful therapy. The next step is an extensive double-blind placebo-controlled study at a large university hospital, "says Anke Rauterkus, CEO of Resaphene Suisse AG.
As part of the highly complex procedure, the project management for patenting was replaced by a long-term experienced project manager by the Board of Directors. This led to a significant shortening of the process. The Board is now expecting the swift completion of the US patent application.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.